Moderna Finds ‘Robust Antibody Response’ in Omicron-Specific Booster
June 8, 2022 — Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday. The neutralizing antibody response was eight times greater at 1 month following a 50-mcg dose with the booster containing both the original mRNA-1273 … Read more
